Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-11

Clinical Trial Update: Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route [Phase 4]

View source ↗

Summary

Phase 4 trial investigating how the route of administration of estradiol affects inflammatory-immune responses in postmenopausal women; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ESTRADIOL (Estradiol)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Postmenopausal | Phase 4 | Status: COMPLETED